A deep learning-based application for COVID-19 diagnosis on CT: The Imaging COVID-19 AI initiative

Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds

Chest disease refers to a wide range of conditions affecting the lungs, such as COVID-19, lung cancer (LC), consolidation lung (COL), and many more. When diagnosing chest disorders medical professionals may be thrown off by the overlapping symptoms (such as fever, cough, sore throat, etc.). Additionally, researchers and medical professionals make use of chest X-rays (CXR), cough sounds, and computed tomography (CT) scans to diagnose chest disorders. The present study aims to classify the nine different conditions of chest disorders, including COVID-19, LC, COL, atelectasis (ATE), tuberculosis (TB), pneumothorax (PNEUTH), edema (EDE), pneumonia (PNEU). Thus, we suggested four novel convolutional neural network (CNN) models that train distinct image-level representations for nine different chest disease classifications by extracting features from images. Furthermore, the proposed CNN employed several new approaches such as a max-pooling layer, batch normalization layers (BANL), dropout, rank-based average pooling (RBAP), and multiple-way data generation (MWDG). The scalogram method is utilized to transform the sounds of coughing into a visual representation. Before beginning to train the model that has been developed, the SMOTE approach is used to calibrate the CXR and CT scans as well as the cough sound images (CSI) of nine different chest disorders. The CXR, CT scan, and CSI used for training and evaluating the proposed model come from 24 publicly available benchmark chest illness datasets. The classification performance of the proposed model is compared with that of seven baseline models, namely Vgg-19, ResNet-101, ResNet-50, DenseNet-121, EfficientNetB0, DenseNet-201, and Inception-V3, in addition to state-of-the-art (SOTA) classifiers. The effectiveness of the proposed model is further demonstrated by the results of the ablation experiments. The proposed model was successful in achieving an accuracy of 99.01%, making it superior to both the baseline models and the SOTA classifiers. As a result, the proposed approach is capable of offering significant support to radiologists and other medical professionals.

Clinical decision support systems (CDSS) in assistance to COVID-19 diagnosis: A scoping review on types and evaluation methods

Background and Aims

Due to the COVID-19 pandemic, a precise and reliable diagnosis of this disease is critical. The use of clinical decision support systems (CDSS) can help facilitate the diagnosis of COVID-19. This scoping review aimed to investigate the role of CDSS in diagnosing COVID-19.

Methods

We searched four databases (Web of Science, PubMed, Scopus, and Embase) using three groups of keywords related to CDSS, COVID-19, and diagnosis. To collect data from studies, we utilized a data extraction form that consisted of eight fields. Three researchers selected relevant articles and extracted data using a data collection form. To resolve any disagreements, we consulted with a fourth researcher.

Results

A search of the databases retrieved 2199 articles, of which 68 were included in this review after removing duplicates and irrelevant articles. The studies used nonknowledge-based CDSS (n = 52) and knowledge-based CDSS (n = 16). Convolutional Neural Networks (CNN) (n = 33) and Support Vector Machine (SVM) (n = 8) were employed to design the CDSS in most of the studies. Accuracy (n = 43) and sensitivity (n = 35) were the most common metrics for evaluating CDSS.

Conclusion

CDSS for COVID-19 diagnosis have been developed mainly through machine learning (ML) methods. The greater use of these techniques can be due to their availability of public data sets about chest imaging. Although these studies indicate high accuracy for CDSS based on ML, their novelty and data set biases raise questions about replacing these systems as clinician assistants in decision-making. Further studies are needed to improve and compare the robustness and reliability of nonknowledge-based and knowledge-based CDSS in COVID-19 diagnosis.

Exploring transfer learning in chest radiographic images within the interplay between COVID-19 and diabetes

The intricate relationship between COVID-19 and diabetes has garnered increasing attention within the medical community. Emerging evidence suggests that individuals with diabetes may experience heightened vulnerability to COVID-19 and, in some cases, develop diabetes as a post-complication following the viral infection. Additionally, it has been observed that patients taking cough medicine containing steroids may face an elevated risk of developing diabetes, further underscoring the complex interplay between these health factors. Based on previous research, we implemented deep-learning models to diagnose the infection via chest x-ray images in coronavirus patients. Three Thousand (3000) x-rays of the chest are collected through freely available resources. A council-certified radiologist discovered images demonstrating the presence of COVID-19 disease. Inception-v3, ShuffleNet, Inception-ResNet-v2, and NASNet-Large, four standard convoluted neural networks, were trained by applying transfer learning on 2,440 chest x-rays from the dataset for examining COVID-19 disease in the pulmonary radiographic images examined. The results depicted a sensitivity rate of 98 % (98%) and a specificity rate of almost nightly percent (90%) while testing those models with the remaining 2080 images. In addition to the ratios of model sensitivity and specificity, in the receptor operating characteristics (ROC) graph, we have visually shown the precision vs. recall curve, the confusion metrics of each classification model, and a detailed quantitative analysis for COVID-19 detection. An automatic approach is also implemented to reconstruct the thermal maps and overlay them on the lung areas that might be affected by COVID-19. The same was proven true when interpreted by our accredited radiologist. Although the findings are encouraging, more research on a broader range of COVID-19 images must be carried out to achieve higher accuracy values. The data collection, concept implementations (in MATLAB 2021a), and assessments are accessible to the testing group.